Santica M. Marcovina

Research.com Recognitions

• 2025 - Research.com Best Female Scientists Award

Overview

Best Publications

• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

  Valery T. Miller;John LaRosa;Vanessa Barnabei;Craig Kessler

  2130
  Citations

• Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

  S Erqou;S Kaptoge;PL Perry;E Di Angelantonio

  1788
  Citations

• Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012

  Elizabeth J. Mayer-Davis;Jean M. Lawrence;Dana Dabelea;Jasmin Divers

  1565
  Citations

• The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

  Trevor J. Orchard;Marinella Temprosa;Ronald Goldberg;Steven Haffner

  1260
  Citations

• Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

  Tomas Vaisar;Subramaniam Pennathur;Pattie S. Green;Sina A. Gharib

  1100
  Citations

• Incidence of diabetes in youth in the United States.

  Dana Dabelea;Ronny A Bell;Ralph B D'Agostino

  1012
  Citations

• The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study

  Angela D Liese;Ralph B D'Agostino;Richard F Hamman

  963
  Citations

• The Diabetes Prevention Program: Design and methods for a clinical trial in the prevention of type 2 diabetes

  G. A. Bray;K. S. Polonsky;P. G. Watson;R. B. Goldberg

  908
  Citations

• Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.

  Robert Ratner;Ronald Goldberg;Steven Haffner;Santica Marcovina

  790
  Citations

• Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors

  Daniel Périard;Amalio Telenti;Philippe Sudre;Jean Jacques Cheseaux

  749
  Citations

• Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis

  Kevin D. O’Brien;Dennis D. Reichenbach;Santica M. Marcovina;Johanna Kuusisto

  701
  Citations

• Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

  Nicholas J Viney;Julian C van Capelleveen;Richard S Geary;Shuting Xia

  699
  Citations

• Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

  P J Barter;C M Ballantyne;R Carmena;M Castro Cabezas

  639
  Citations

• Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood.

  Dana Dabelea;Jeanette M. Stafford;Elizabeth J. Mayer-Davis;Ralph D’Agostino

  623
  Citations

• Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): A randomised open-label substudy

  Lenore J. Launer;Michael E. Miller;Jeff D. Williamson;Ron M. Lazar

  622
  Citations

• Effect of excessive weight gain with intensive therapy of type 1 Diabetes on lipid levels and blood pressure : Results from the DCCT

  Jonathan Q. Purnell;John E. Hokanson;Santica M. Marcovina;Michael W. Steffes

  583
  Citations

• Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial

  Tali Cukierman-Yaffe;Tali Cukierman-Yaffe;Hertzel C Gerstein;Jeff D. Williamson;Ronald M Lazar

  550
  Citations

• Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study

  Vanita R. Aroda;Sharon L. Edelstein;Ronald B. Goldberg;William C. Knowler

  549
  Citations

• The SEARCH for Diabetes in Youth study: rationale, findings, and future directions.

  Richard F. Hamman;Ronny A. Bell;Dana Dabelea;Ralph B. D’Agostino

  545
  Citations

• Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study

  Sotirios Tsimikas;Sotirios Tsimikas;Nicholas J Viney;Steven G Hughes;Walter Singleton

  543
  Citations